Lombard Odier Asset Management (Usa) Corp Eli Lilly & CO Put Options Transaction History

Lombard Odier Asset Management (Usa) Corp

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $17.8 Million - $23.8 Million	30,000 New	30,000 $23.3 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $4.93 Million - $6.38 Million	-30,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $3.91 Million - $5.18 Million	30,000 New	30,000 $5.07 Million

3,719

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.